Analystreport

Orchard Therapeutics plc (NASDAQ: ORTX) had its price target lowered by analysts at Cantor Fitzgerald from $17.00 to $12.00. They now have an "overweight" rating on

Orchard Therapeutics plc - American Depositary Shares  (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report